Denali Therapeutics Inc (NASDAQ:DNLI)

74.93
BATS BZX Real-Time Price
As of 2:41pm ET
 +1.33 / +1.81%
Today’s Change
22.36
Today|||52-Week Range
93.94
-10.54%
Year-to-Date

Today’s Trading

Previous close73.60
Today’s open73.57
Day’s range73.48 - 75.00
Volume12,442
Average volume (3 months)554,690
Market cap$9.1B
Data as of 2:41pm ET, 06/17/2021

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-388.66%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,158.19%
P/E ratio124.9
Price/Sales28.12
Price/Book7.86

Competitors

 Today’s
change
Today’s
% change
IBRXImmunitybio Inc-0.37-2.59%
----
TLRYTilray Inc-0.30-1.65%
HALOHalozyme Therapeutic...-0.19-0.44%
Data as of 2:41pm ET, 06/17/2021

Financials

Next reporting dateAugust 12, 2021
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$335.7M
Annual profit (last year)$71.1M
Net profit margin21.19%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Francisco, California

Forecasts